Nobori Drug Eluting Stent is indicated for improving luminal diameter and reducing in-stent restenosis for the treatment of coronary artery lesions. The design of the Nobori stent, which features a biolimus A91 drug and biodegradable polymer, is coated only on the abluminal side of the stent.

Nobori Drug Eluting Stent is indicated for improving luminal diameter and reducing in-stent restenosis for the treatment of coronary artery lesions. The design of the Nobori stent, which features a biolimus A91 drug and biodegradable polymer, is coated only on the abluminal side of the stent.